INS and cancer: Finally, we used this variant to examine potential downstream mediators of GIPR signaling (i.e. various measures of childhood and adult adiposity, fasting and postprandial glucose and insulin, other glycemic traits, endogenous sex hormones, and lipids), to identify possible mechanisms underpinning the effect of impaired GIPR signaling on cancer risk.